; and (x) support for the integration of TB diagnosis, treatment, and prevention activities into primary health care, as appropriate. (c) Definitions In this section: (1) Appropriate congressional committees The term appropriate congressional committees means the Committee on Foreign Relations of the Senate and the Committee on Foreign Affairs of the House of Representatives . (2) End TB Strategy The term End TB Strategy means the strategy to eliminate TB that was approved by the World Health Assembly in May 2014, and is described in The End TB Strategy: Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015 . (3) Global alliance for tuberculosis drug development The term Global Alliance for Tuberculosis Drug Development means the public-private partnership that bring together leaders in health, science, philanthropy, and private industry to devise new approaches to TB. (4) Global tuberculosis drug facility The term Global Tuberculosis Drug Facility means the initiative of the Stop Tuberculosis Partnership to increase access to the most advanced, affordable, quality-assured TB drugs and diagnostics. (5) MDR–TB The term MDR–TB means multi-drug-resistant TB. (6) Stop tuberculosis partnership The term Stop Tuberculosis Partnership means the partnership of 1,600 organizations (including international and technical organizations, government programs, research and funding agencies, foundations, nongovernmental organizations, civil society and community groups, and the private sector), donors, including the United States, high TB burden countries, multilateral agencies, and nongovernmental and technical agencies, which is governed by the Stop TB Partnership Coordinating Board and hosted by a United Nations entity, committed to short- and long-term measures required to control and eventually eliminate TB as a public health problem in the world. (7) XDR–TB The term XDR–TB means extensively drug-resistant TB. (d) Authorization To carry out this section, the President is authorized, consistent